Centessa Pharmaceuticals (CNTA) Interest & Investment Income (2022 - 2025)
Historic Interest & Investment Income for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to $3.8 million.
- Centessa Pharmaceuticals' Interest & Investment Income rose 1272.46% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 7250.5%. This contributed to the annual value of $14.0 million for FY2024, which is 3379.15% up from last year.
- As of Q3 2025, Centessa Pharmaceuticals' Interest & Investment Income stood at $3.8 million, which was up 1272.46% from $4.4 million recorded in Q2 2025.
- Centessa Pharmaceuticals' 5-year Interest & Investment Income high stood at $7.9 million for Q1 2025, and its period low was $25000.0 during Q2 2022.
- In the last 4 years, Centessa Pharmaceuticals' Interest & Investment Income had a median value of $2.9 million in 2023 and averaged $2.7 million.
- In the last 5 years, Centessa Pharmaceuticals' Interest & Investment Income soared by 813600.0% in 2023 and then surged by 237.06% in 2024.
- Quarter analysis of 4 years shows Centessa Pharmaceuticals' Interest & Investment Income stood at $39000.0 in 2022, then soared by 7420.51% to $2.9 million in 2023, then soared by 65.19% to $4.8 million in 2024, then fell by 22.29% to $3.8 million in 2025.
- Its Interest & Investment Income stands at $3.8 million for Q3 2025, versus $4.4 million for Q2 2025 and $7.9 million for Q1 2025.